HEADER OXIDOREDUCTASE 23-JAN-07 2ONF TITLE CRYSTAL STRUCTURE OF A PUTATIVE OSMOTICALLY INDUCIBLE PROTEIN C TITLE 2 (TA0195) FROM THERMOPLASMA ACIDOPHILUM AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL PROTEIN TA0195; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOPLASMA ACIDOPHILUM; SOURCE 3 ORGANISM_TAXID: 2303; SOURCE 4 STRAIN: AMRC-C165, DSM1728, IFO15155, JCM9062; SOURCE 5 ATCC: 25905; SOURCE 6 GENE: NP_393673.1, TA0195; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-OCT-17 2ONF 1 REMARK REVDAT 5 18-OCT-17 2ONF 1 REMARK REVDAT 4 13-JUL-11 2ONF 1 VERSN REVDAT 3 23-MAR-11 2ONF 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2ONF 1 VERSN REVDAT 1 06-FEB-07 2ONF 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (NP_393673.1) FROM JRNL TITL 2 THERMOPLASMA ACIDOPHILUM AT 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 33399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1697 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2292 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 121 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2260 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 28.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.39000 REMARK 3 B22 (A**2) : -0.42000 REMARK 3 B33 (A**2) : 2.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.96000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.102 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.534 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2507 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1765 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3415 ; 1.696 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4307 ; 0.972 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 315 ; 5.879 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 125 ;37.429 ;24.080 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 440 ;13.784 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;20.214 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2767 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 511 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 413 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1836 ; 0.206 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1137 ; 0.181 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1299 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 244 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.160 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 25 ; 0.253 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1621 ; 2.319 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 579 ; 0.572 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2391 ; 2.886 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1154 ; 5.092 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1005 ; 6.907 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 139 REMARK 3 RESIDUE RANGE : B 0 B 139 REMARK 3 ORIGIN FOR THE GROUP (A): 24.8092 12.0500 10.5566 REMARK 3 T TENSOR REMARK 3 T11: -0.0425 T22: -0.0208 REMARK 3 T33: -0.0570 T12: 0.0134 REMARK 3 T13: -0.0007 T23: -0.0105 REMARK 3 L TENSOR REMARK 3 L11: 1.0474 L22: 0.9590 REMARK 3 L33: 0.3031 L12: 0.6326 REMARK 3 L13: -0.1780 L23: -0.1927 REMARK 3 S TENSOR REMARK 3 S11: -0.0170 S12: -0.1015 S13: 0.0270 REMARK 3 S21: 0.0081 S22: 0.0109 S23: 0.0178 REMARK 3 S31: 0.0103 S32: 0.0121 S33: 0.0061 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN RIDING POSITIONS. REMARK 3 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 4. ONE COENZYME A (COA) MONOMER WAS MODELED IN THE REMARK 3 ACTIVE SITE BASED ON THE PRESENCE OF CLEAR AND REMARK 3 CONCLUSIVE ELECTRON DENSITY. REMARK 4 REMARK 4 2ONF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041351. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97910 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33417 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 27.929 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 30.0% PEG-6000, 0.1M MES PH REMARK 280 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.27500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS THE ASSIGNMENT OF A DIMER AS A REMARK 300 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 94 CD CE NZ REMARK 470 ARG B 92 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 15 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 127 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 11 -70.83 -81.64 REMARK 500 ASP A 13 -130.80 48.85 REMARK 500 ARG A 14 48.66 -109.33 REMARK 500 LYS A 86 165.50 73.74 REMARK 500 ASN A 128 -11.58 75.14 REMARK 500 ASP B 13 -124.04 48.15 REMARK 500 LYS B 86 168.91 69.66 REMARK 500 ASN B 128 -9.49 72.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COA B 140 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 140 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 141 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 141 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 142 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 370499 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 2ONF A 1 139 UNP Q9HLN2 Q9HLN2_THEAC 1 139 DBREF 2ONF B 1 139 UNP Q9HLN2 Q9HLN2_THEAC 1 139 SEQADV 2ONF GLY A 0 UNP Q9HLN2 LEADER SEQUENCE SEQADV 2ONF MSE A 1 UNP Q9HLN2 MET 1 MODIFIED RESIDUE SEQADV 2ONF MSE A 65 UNP Q9HLN2 MET 65 MODIFIED RESIDUE SEQADV 2ONF MSE A 113 UNP Q9HLN2 MET 113 MODIFIED RESIDUE SEQADV 2ONF GLY B 0 UNP Q9HLN2 LEADER SEQUENCE SEQADV 2ONF MSE B 1 UNP Q9HLN2 MET 1 MODIFIED RESIDUE SEQADV 2ONF MSE B 65 UNP Q9HLN2 MET 65 MODIFIED RESIDUE SEQADV 2ONF MSE B 113 UNP Q9HLN2 MET 113 MODIFIED RESIDUE SEQRES 1 A 140 GLY MSE HIS VAL TYR GLU SER ASP VAL SER TRP ILE ASP SEQRES 2 A 140 ASP ARG ARG THR GLU VAL SER VAL GLY ASP HIS ARG ILE SEQRES 3 A 140 GLU VAL ASP SER PRO PRO GLU PHE GLY GLY PRO GLU GLY SEQRES 4 A 140 GLN LEU TYR PRO GLU THR LEU PHE PRO SER VAL LEU ALA SEQRES 5 A 140 SER CYS LEU LEU THR THR PHE LEU GLU PHE LYS ASP ARG SEQRES 6 A 140 MSE GLY ILE ASN LEU LYS SER TRP ASN SER HIS VAL THR SEQRES 7 A 140 ALA GLU LEU GLY PRO SER PRO GLU LYS GLY PHE LYS PHE SEQRES 8 A 140 HIS ARG ILE LYS ILE HIS VAL LYS ILE GLY VAL ASN ASP SEQRES 9 A 140 GLU ASP LYS GLU LYS ILE PRO ARG ALA MSE GLN LEU ALA SEQRES 10 A 140 GLU LYS TYR CYS PHE ILE SER ARG ALA ILE ARG ASN ASN SEQRES 11 A 140 VAL GLU GLU ILE VAL ASP TYR GLU PHE VAL SEQRES 1 B 140 GLY MSE HIS VAL TYR GLU SER ASP VAL SER TRP ILE ASP SEQRES 2 B 140 ASP ARG ARG THR GLU VAL SER VAL GLY ASP HIS ARG ILE SEQRES 3 B 140 GLU VAL ASP SER PRO PRO GLU PHE GLY GLY PRO GLU GLY SEQRES 4 B 140 GLN LEU TYR PRO GLU THR LEU PHE PRO SER VAL LEU ALA SEQRES 5 B 140 SER CYS LEU LEU THR THR PHE LEU GLU PHE LYS ASP ARG SEQRES 6 B 140 MSE GLY ILE ASN LEU LYS SER TRP ASN SER HIS VAL THR SEQRES 7 B 140 ALA GLU LEU GLY PRO SER PRO GLU LYS GLY PHE LYS PHE SEQRES 8 B 140 HIS ARG ILE LYS ILE HIS VAL LYS ILE GLY VAL ASN ASP SEQRES 9 B 140 GLU ASP LYS GLU LYS ILE PRO ARG ALA MSE GLN LEU ALA SEQRES 10 B 140 GLU LYS TYR CYS PHE ILE SER ARG ALA ILE ARG ASN ASN SEQRES 11 B 140 VAL GLU GLU ILE VAL ASP TYR GLU PHE VAL MODRES 2ONF MSE A 1 MET SELENOMETHIONINE MODRES 2ONF MSE A 65 MET SELENOMETHIONINE MODRES 2ONF MSE A 113 MET SELENOMETHIONINE MODRES 2ONF MSE B 1 MET SELENOMETHIONINE MODRES 2ONF MSE B 65 MET SELENOMETHIONINE MODRES 2ONF MSE B 113 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 65 8 HET MSE A 113 13 HET MSE B 1 8 HET MSE B 65 8 HET MSE B 113 13 HET EDO A 140 4 HET EDO A 141 8 HET EDO A 142 4 HET COA B 140 48 HET EDO B 141 4 HETNAM MSE SELENOMETHIONINE HETNAM EDO 1,2-ETHANEDIOL HETNAM COA COENZYME A HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 EDO 4(C2 H6 O2) FORMUL 6 COA C21 H36 N7 O16 P3 S FORMUL 8 HOH *306(H2 O) HELIX 1 1 PRO A 30 GLY A 34 5 5 HELIX 2 2 TYR A 41 MSE A 65 1 25 HELIX 3 3 ASP A 103 GLU A 107 5 5 HELIX 4 4 LYS A 108 CYS A 120 1 13 HELIX 5 5 CYS A 120 ARG A 127 1 8 HELIX 6 6 PRO B 30 GLY B 34 5 5 HELIX 7 7 TYR B 41 GLY B 66 1 26 HELIX 8 8 ASP B 103 GLU B 107 5 5 HELIX 9 9 LYS B 108 CYS B 120 1 13 HELIX 10 10 CYS B 120 ARG B 127 1 8 SHEET 1 A 6 HIS A 23 ASP A 28 0 SHEET 2 A 6 ARG A 15 VAL A 20 -1 N VAL A 18 O ILE A 25 SHEET 3 A 6 HIS A 2 TRP A 10 -1 N ASP A 7 O SER A 19 SHEET 4 A 6 LEU B 69 PRO B 82 -1 O VAL B 76 N SER A 6 SHEET 5 A 6 PHE B 88 VAL B 101 -1 O LYS B 98 N ASN B 73 SHEET 6 A 6 GLU B 131 PHE B 138 1 O ILE B 133 N ILE B 95 SHEET 1 B 6 GLU A 131 PHE A 138 0 SHEET 2 B 6 PHE A 88 VAL A 101 1 N VAL A 97 O ASP A 135 SHEET 3 B 6 LEU A 69 PRO A 82 -1 N LYS A 70 O GLY A 100 SHEET 4 B 6 HIS B 2 ASP B 12 -1 O SER B 6 N VAL A 76 SHEET 5 B 6 ARG B 15 VAL B 20 -1 O SER B 19 N ASP B 7 SHEET 6 B 6 HIS B 23 ASP B 28 -1 O ILE B 25 N VAL B 18 LINK C GLY A 0 N MSE A 1 1555 1555 1.35 LINK C MSE A 1 N HIS A 2 1555 1555 1.34 LINK C ARG A 64 N MSE A 65 1555 1555 1.33 LINK C MSE A 65 N GLY A 66 1555 1555 1.32 LINK C ALA A 112 N MSE A 113 1555 1555 1.33 LINK C MSE A 113 N GLN A 114 1555 1555 1.33 LINK C GLY B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N HIS B 2 1555 1555 1.33 LINK C ARG B 64 N MSE B 65 1555 1555 1.34 LINK C MSE B 65 N GLY B 66 1555 1555 1.32 LINK C ALA B 112 N MSE B 113 1555 1555 1.32 LINK C MSE B 113 N GLN B 114 1555 1555 1.31 CISPEP 1 GLY A 0 MSE A 1 0 4.87 SITE 1 AC1 26 PHE A 33 ARG A 64 LYS A 86 GLY A 87 SITE 2 AC1 26 GLU B 32 THR B 56 PHE B 61 ARG B 64 SITE 3 AC1 26 MSE B 65 ARG B 111 LEU B 115 LYS B 118 SITE 4 AC1 26 TYR B 119 HOH B 147 HOH B 152 HOH B 155 SITE 5 AC1 26 HOH B 171 HOH B 176 HOH B 178 HOH B 189 SITE 6 AC1 26 HOH B 222 HOH B 231 HOH B 258 HOH B 259 SITE 7 AC1 26 HOH B 260 HOH B 263 SITE 1 AC2 4 LYS A 108 ARG A 111 HOH A 143 HOH A 273 SITE 1 AC3 3 LYS A 70 TRP B 10 ILE B 11 SITE 1 AC4 4 TRP A 10 ILE A 11 ASP A 12 LYS B 70 SITE 1 AC5 1 ARG A 64 CRYST1 47.070 68.550 48.670 90.00 98.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021250 0.000000 0.003100 0.00000 SCALE2 0.000000 0.014590 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020760 0.00000 MASTER 344 0 11 10 12 0 11 6 0 0 0 22 END